Categories: News

Viridian Therapeutics to Participate in the Wedbush PacGrow Healthcare Virtual Conference

BOULDER, Colo., Aug. 05, 2021 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies, today announced that Jonathan Violin, Ph.D., President and Chief Executive Officer, and Barrett Katz, M.D., M.B.A., Chief Medical Officer of Viridian, will participate in a panel presentation at the Wedbush PacGrow Healthcare Virtual Conference, which is scheduled to take place from August 10 – 11, 2021.

Event: The Wedbush PacGrow Healthcare Virtual Conference
Panel: TED Talk – State of Play in Thyroid Eye Disease (TED)
Date: Wednesday, August 11th
Fireside Chat Time: 1:45 p.m. ET

Webcast information for this event will be accessible on the Events page under the Investors section of the Viridian Therapeutics website at www.viridiantherapeutics.com. A replay of this panel will be archived on the website and available for approximately 90 days following the live event.

About Viridian Therapeutics

Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian’s most advanced program, VRDN-001, is an anti-IGF-1R monoclonal antibody in development for TED, a debilitating auto-immune disease that causes inflammation and fibrosis within the orbit of the eye which can cause double vision, pain, and potential blindness. Patients with severe disease often require multiple remedial surgeries to the orbit, eye muscles, and eyelids. Viridian is based in Boulder, Colorado, and Waltham, Massachusetts. Learn more about Viridian and its programs at https://www.viridiantherapeutics.com/.

Follow us on Twitter @ViridianThera and on LinkedIn.

Viridian Contacts:
Investors:
Dan Ferry
LifeSci Advisors
617-430-7576
IR@viridiantherapeutics.com

Media:
Darby Pearson
Verge Scientific Communications
703-587-0831
PR@viridiantherapeutics.com

Staff

Recent Posts

Bharat Rajagopal Joins Verily as Chief Revenue Officer

Former Microsoft life sciences commercial leader brings extensive experience advancing digital transformation across healthcare and…

1 hour ago

Lotus Weight Loss & Wellness Achieves 30% Increase in Patient Visits with eClinicalWorks EHR and healow Patient Engagement Solutions

healow Open Access online appointment solution assists the women-owned startup practice in streamlining operationsWESTBOROUGH, Mass.--(BUSINESS…

1 hour ago

Miach Orthopaedics Raises $20 Million in Series B Extension

The Major League Soccer Players Association (MLSPA), SV Health Investors and Aperture Venture Partners Join…

1 hour ago

Glidewell Unveils New Glidewell HT(TM) Implant System

Leading dental manufacturer rebrands its popular Hahn™ Tapered Implant System with $99 everyday priceNEWPORT BEACH,…

1 hour ago

DistillerSR Launches CuratorCR Collaboration to Enable Seamless Sharing of Literature Repositories Across Departments and Organizations

Research Organizations Can Now Securely Co-Create and Share Curated Reference Repositories in Real TimeOTTAWA, ON…

1 hour ago

Bux Pain Management Introduces Innovative SynchroMed III Pain Pump to Its Practice

Integrating this new solution reflects on Bux Pain Management's commitment to delivering the most advanced…

1 hour ago